In 1912, Fritz Heinrich Lewy described neuronal inclusions in the brain of patients who had suffered from Paralysis agitans (i.e., Parkinson's disease). Later, these findings became the so-called "Lewy bodies." However, little is known about the man who made this discovery. Our aim was to investigate Lewy's private and professional life and to gather information for a detailed biography. We contacted over 100 archives, libraries, and museums in Germany, Poland, Switzerland, United Kingdom, and United States. Over 300 documents, publications, and photos were collected. Lewy was born in Berlin, Germany in 1885 and lived there until 1933. After his dismissal on racial grounds by the Nazis, Lewy emigrated to England in 1933 and to the United States of America in 1934, where he lived and worked until his death in 1950. This article gives a summary of Lewy's life and briefly presents his contribution to German and American neurology.
Wie fügt sich die Verordnung Reach in das europäische Regelwerk zum Umgang mit Chemikalien ein? Nach langen Verhandlungen trat Reach vor drei Jahren in Kraft. Ende November endet die erste Übergangfrist zur Registrierung von Altstoffen.
Das europäische Chemikalienrecht bleibt uneinheitlich — auch nachdem Reach und GHS in Kraft getreten sind. Die jeweils geltende Regelung muss sich der Bürger aus vielen Vorschriften heraussuchen; dabei sind die Grenzen oft unscharf.
Einstufungen, Kennzeichnungen und Sicherheitsdatenblätter ändern sich mit den neuen Verordnungen zur Registrierung und Verpackung. Dazu gehören neue Begriffe wie “akut toxisch der Kategorie 1 bis 3” statt “sehr giftig” und “giftig”.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.